An offering was filed with the SEC on July 22, 2025, involving Simmons Bank, with joint book-running management from Stephens Inc., Keefe, Bruyette & Woods, and Morgan Stanley, and co-management from Robert W. Baird & Co.

The entities involved

• Simmons Bank →

  United States financial company based in Arkansas

  • Simmons Bank and Associated Banc-Corp are both identified as mid-cap finance companies.Sat 18:47
• Stephens Inc. →

  private equity firm

  • Financial firms, including Stephens Inc., Nuveen Sl Tfip, and Royal Bank of Canada, increased their holdings in a company stock traded on the NYSE.Sun 20:51
• Keefe, Bruyette & Woods →

  investment bank

  • Keefe, Bruyette & Woods began coverage of Franklin Resources, and Morgan Stanley subsequently upped its target price and rating.Mon 07:24
  • Keefe, Bruyette & Woods initiated investment research coverage on Greek bank stocks, including National Bank of Greece.Mon 07:15
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

• First Merchants Corporation is pursuing an offering, with Keefe, Bruyette & Woods appointed as the sole book-running manager, requiring filings with the SEC.Sep 24
• SB Energy plans a U.S. IPO seeking a Nasdaq Global Select Market listing, with Morgan Stanley, Goldman Sachs, and Citigroup as joint lead book-running managers.Sep 2
• TD Cowen and Morgan Stanley were appointed as lead book-running managers for a new offering in New York.Fri 03:31
• Kratos Defense & Security Solutions filed a shelf registration statement with the SEC, with Robert W. Baird & Co. and RBC Capital Markets acting as joint book-running managers.Jun 8
• Goldman Sachs and Morgan Stanley engaged in joint book-running management of a bond issuance for AstraZeneca.Aug 25